BOSTON SCIENTIFIC CORP (BSX) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BOSTON SCIENTIFIC CORP (BSX) CIK: 0000885725 --- Reporting Owner --- Name: Monson Jonathan CIK: 0001779170 Role: Officer (EVP and CFO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: +2,087 | Price: $0.00 Shares Owned After: 40,073 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. [Transaction #2] Security: Common Stock Date: 2026-07-01 | Code: F (Payment of exercise/tax) Shares: -1,010 | Price: $43.06 Total Value: $43,490.60 Shares Owned After: 39,063 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: -2,087 | Price: $0.00 Exercisable: N/A | Expires: 2029-07-01 Shares Owned After: 6,263 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. [F2] Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant. [F2] Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant. --- Footnotes (Complete Index) --- F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant. --- Signature --- /s/ /s/ Susan Thompson, Attorney-in-Fact (2026-07-02)